coversyl comp novum 10 mg / 2,5 mg tabletti, kalvopäällysteinen
paranova oy - indapamide, perindopril arginine - tabletti, kalvopäällysteinen - 10 mg / 2,5 mg - perindopriili ja diureetit
coversyl novum 10 mg tabletti, kalvopäällysteinen
paranova oy - perindoprilum argininum - tabletti, kalvopäällysteinen - 10 mg - perindopriili
coversyl novum 10 mg tabletti, kalvopäällysteinen
orifarm oy - perindoprilum argininum - tabletti, kalvopäällysteinen - 10 mg - perindopriili
solvetta 0.120 mg / 0.015 mg / 24 h depotlääkevalmiste, emättimeen
sandoz a/s sandoz a/s - ethinylestradiolum,etonogestrelum - depotlääkevalmiste, emättimeen - 0.120 mg / 0.015 mg / 24 h - progestogeeniä ja estrogeeniä sisältävät emätinrenkaat
novamune injektiokonsentraatti ja liuotin, suspensiota varten
ceva-phylaxia co. ltd. - ibd elävä heikennetty virus, serotyyppi 1, kanta syza26 - injektiokonsentraatti ja liuotin, suspensiota varten - gumboron tauti -rokote
cevac md rispens injektiokonsentraatti ja liuotin, suspensiota varten
ceva-phylaxia veterinary biologicals co. ltd. - marek's disease virus, serotype 1, cvi-988 - injektiokonsentraatti ja liuotin, suspensiota varten - marekin tauti -rokote
ultifend nd ibd
ceva-phylaxia veterinary biologicals co. ltd - turkey herpes virus, strain rhvt/nd/ibd, expressing the fusion protein of newcastle disease virus and the vp2 protein of infectious bursal disease virus, live recombinant - immunologiset lääkkeet - embryonated chicken eggs; chicken - for the active immunisation of one-day-old chicks or 18-day-old chicken embryonated eggs to reduce mortality, clinical signs and lesions caused by newcastle disease virus (ndv) and to reduce virus shedding; to reduce mortality, clinical signs and bursa lesions caused by very virulent infectious bursal disease virus (ibdv); to reduce mortality, clinical signs and lesions caused by classical marek’s disease virus (mdv).
vectormune fp ilt + ae
ceva-phylaxia co. ltd. - live recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus (rfp-lt) and avian encephalomyelitis virus, strain calnek 1143 (ae) - immunologicals for aves, live viral vaccines, domestic fowl - kana - for active immunisation of chickens of 8 to 13 weeks of age in order to reduce the skin lesions due to fowlpox, to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis and to prevent egg production losses due to avian encephalomyelitis.
vectormune fp ilt
ceva-phylaxia co. ltd. - recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live - kana - for active immunisation of chickens from 8 weeks of age in order to reduce the skin lesions due to fowlpox and to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis.
filsuvez
amryt pharmaceuticals dac - dry extract from birch bark (der 5-10 : 1), extraction solvent n-heptane 95% (w/w) - epidermolysis bullosa dystrophica; epidermolysis bullosa, junctional - valmisteet haavojen ja haavaumien hoitoon - treatment of partial thickness wounds associated with dystrophic and junctional epidermolysis bullosa (eb) in patients 6 months and older.